SII launches pneumococcal vaccine, PNEUMOSIL indiagazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiagazette.com Daily Mail and Mail on Sunday newspapers.
The new MHA order has said that as earlier, containment zones will be demarcated carefully where perimeter control will be in place. It has also asked states to ensure that Covid-appropriate behaviour is promoted and strictly enforced; and the Standard Operating Procedures (SOPs) for permitted activities are followed scrupulously.
“Therefore, the focused approach on surveillance, containment and strict observance of the guidelines/ SOPs issued by MHA and Ministry of Health & Family Welfare (MOHFW), as envisaged in the Guidelines issued on 25.11.2020; need to be enforced strictly by States and UTs, ” the order has said.
The MHA has also asked states to be more vigilant owing to New Year celebrations. “Strict vigil is also needed to be maintained to prevent any fresh surge in cases in wake of upcoming New year celebrations and ongoing winter season which are favourable for the spread of the virus. In this regard, appropriate measures may be taken by the State / UT Governments,
Updated:
Govt. order mentions detection of new virulent strain from UK
Share Article
AAA
Workers wearing PPE suits at Mumbai International Airport escort passengers who arrived from United Kingdom. File
| Photo Credit: Emmanual Yogini
Govt. order mentions detection of new virulent strain from UK
The Ministry of Home Affairs (MHA) issued an order on Monday extending the COVID-19 “guidelines for surveillance” till January 31.
In a letter, Union Home Secretary Ajay Bhalla asked all States to instruct the concerned authorities to support the Union Health Ministry in “identification, preparation of database, vaccine delivery, storage, security, shipment and vaccination of beneficiaries”.
The letter said the Government of India has started preparations for administration and roll out of vaccine for COVID-19 under which healthcare workers, frontline workers, persons above 50 years of age and those below 50 years with comorbidities have been prioritised.
The Serum Institute of India, which is manufacturing and testing Oxford/AstraZeneca’s coronavirus vaccine in the country, said on Monday it expected regulatory approval for the shot in a few days. Serum’s Chief Executive Adar Poonawalla said the vaccine, named Covishield in India, should be licensed by January.
“The emergency use authorisation by the UK drug regulator for the Oxford-AstraZeneca vaccine against Covid-19 is expected by December end or first week of January. In India too, we are hoping for regulatory approval for the Covishield vaccine in a few days. We must respect the process and give the drug regulators in the UK and India enough time to review the data. No one wants to compromise on safety and we hope for some good news in the new year,” Poonawalla said.
Updated Dec 28, 2020 | 16:06 IST
The Serum Institute of India announced the launch of India s first, and the only indigenous vaccine against pneumonia in India, on the 28th of December. SII is also producing Oxford COVID vaccine in India. The first and only indigenous Pneumonia vaccine launched by Serum Institute of India | Photo Credit: iStock Images
New Delhi: The Serum Institute of India announced the launch of India s first, and the only indigenous vaccine against pneumonia. The product of the company is named the Pneumococcal Conjugate Vaccine. The launch event was conducted today, December 28th, 2020 from 4-5 pm, virtually.
The launch event for the vaccine was held live wherein Mr Adar Poonawalla, CEO, Serum Institute of India addressed the media in the presence of Dr Harsh Vardhan, Union Minister, Ministry of Health & Family Welfare, Dr Cyrus S. Poonawalla, Chairman and Managing Director, Serum Institute of India and Dr Rajeev Dhere